COLLEGE STATION, TX — Texas A&M says they stand ready to manufacture vaccines for COVID-19.
“The Texas A&M University System completed the construction of two new facilities and the retrofitting of a third site on time and on budget in 2017. The System and its subcontractor, FUJIFILM Diosynth Biotechnologies (FDB), are ready to respond to an order from the federal government to manufacture vaccines. To date, the System has received no federal order," said Laylan Copelin, Vice Chancellor of Marketing and Communications.
FUJIFILM Diosynth Biotechnologies (FDB) owns and operates the facilities capable of manufacturing a wide range of vaccines and therapeutic products, according to Copelin.
"This means the facilities and a trained workforce are able to respond quickly as soon as a COVID-19 vaccine is developed and safely tested," said Copelin.
